Objective: To investigate whether 5alpha-reductase inhibitor and dihydrotestosterone (DHT) play a role in spermatogenesis in male rats.
Methods: Thirty-two male rats were divided into 4 groups (Groups C, T, F and FT). Group C received plant oil injection and oral starch perfusion, Group T testosterone undecanoate (TU, 20 mg/kg) injection and oral starch perfusion, Group F plant oil injection and oral Finasteride perfusion, and Group FT TU (20 mg/kg) injection and oral Finasteride perfusion. Data on serum T and DHT, sperm count, sperm mobility and reproductive function were collected and analysed.
Results: (1) 5alpha-reductase inhibitor, Finasteride and TU reduced the weight of the testis and epididymis in the experiment groups compared with the negative control (Group C), but TU increased the weight of the prostate while Finasteride decreased it compared with the positive control (Group T). TU combined with Finasteride could counteract the effect of the weight increase of the prostate, but not that of the testis. (2) Finasteride, or Finasteride combined with TU, reduced the DHT but increased the testosterone level in comparison with the control group. (3) Both Finasteride and TU could inhibit epididymal sperm count and reproductive function compared with the control, but the effect was less significant in Group FT than in Group F.
Conclusion: High dosages of 5alpha-reductase inhibitor, Finasteride, can suppress male reproductive function, but the inhibiting effect could be counteracted by administration of 5alpha-reductase inhibitor along with TU.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Early experience of prostate artery embolization: a retrospective single-centre study.
Scand J Urol
January 2025
Center for Clinical Research Västmanland, Uppsala University, Sweden; Division of Surgery, Danderyd University Hospital, Stockholm, Sweden.
Objective: The aim of this study was to evaluate the early experiences of prostate artery embolization (PAE) in patients with benign prostatic hyperplasia (BPH).
Material And Methods: This retrospective study included all patients treated for BPH who were referred to the radiology department for PAE in Västmanland between 2018 and 2021. Data were collected on patient demographics, International Prostate Symptom Score (IPSS), prostate-specific antigen level, and peri- and post-procedure outcomes.
Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury-a randomized, double-blind, and placebo-controlled pilot study.
Front Neurol
December 2024
Brain Rehabilitation Research Center, Malcom Randall Department of Veterans Affairs Medical Center, North Florida/South Georgia Veterans Health System, Gainesville, FL, United States.
Article Synopsis
- High-dose testosterone replacement therapy (TRT) combined with finasteride offers benefits such as improved body composition, muscle strength, and bone density in older men, while mitigating the risk of prostate enlargement.
- A pilot study involved 12 men with spinal cord injuries, demonstrating that TRT with finasteride significantly increased lean body mass and muscle size, alongside enhancing bone mineral density compared to a placebo.
- Results suggest TRT + finasteride reduced fat mass and improved muscular strength, with measurable benefits observed as early as 6 months into the treatment, indicating its potential effectiveness for men with low testosterone post-injury.
Phytomedicines in Pharmacotherapy of LUTS/BPH - What Do Patients Think?
Patient Prefer Adherence
December 2024
Department of Urology, University Hospital, LMU Munich, Munich, Germany.
Article Synopsis
- The study focuses on lower urinary tract symptoms (LUTS) and the rising interest in phytomedicines as alternatives to traditional medications, especially with limited efficacy of current treatments.
- A survey conducted with 300 patients revealed that a significant portion (41%) of those on medication for LUTS were also using phytomedicines, which showed good tolerability despite lower efficacy ratings.
- Patients expressed a desire for insurance coverage for phytomedicines, highlighting a shift toward individualized treatment options and the importance of patient empowerment in the decision-making process.
The effect of platelet-derived growth factor-aa (PDGFA) conjugated with low-molecular-weight protamine (LMWP) on hair loss improvement effect.
Biochem Biophys Res Commun
January 2025
Department of Pharmaceutical & Cosmetics, Dongshin University, 185, gunjae-ro, Naju, Jeonnam, 58245, Republic of Korea. Electronic address:
Platelet-derived growth factor-AA (PDGFA) is known to play an important role in hair loss and hair growth by involving in the anagen phase of the hair follicle growth cycle. In this study, we synthesized skin-permeable recombinant low-molecular-weight protamine (LMWP)-conjugated PDGFA (LMWP-PDGFA) by linking LMWP to the N terminus of PDGFA. We evaluated the hair loss improvement effect, wound healing efficacy, and skin permeability of LMWP-PDGFA.
View Article and Find Full Text PDFOleanolic acid protects ethanol-induced memory impairments.
Behav Brain Res
March 2025
Department of Korean Internal Medicine, College of Korean Medicine, Sang-Ji University, 3 Sangjidae-gil, Wonju-si, Gangwon-do 26339, Republic of Korea. Electronic address:
Article Synopsis
- * Ethanol affects GABA receptors, leading to changes in neurotransmission that could result in memory loss and increase the likelihood of psychiatric disorders like dementia.
- * Oleanolic acid (OA) was found to protect against ethanol-induced memory impairment by blocking alterations in N-methyl-D-aspartate receptor function, suggesting its potential as a treatment for overcoming Ethanol-related cognitive issues.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!